DEF: Sleep Number Seeks Shareholder Approval for Governance Changes
Proxy Statement
Sleep Number Corporation is holding its 2026 Annual Meeting on May 21, 2026, to vote on key governance proposals, including declassifying the board and eliminating supermajority voting requirements, alongside executive compensation and equity plan amendments.
Summary
- Sleep Number Corporation is holding its 2026 Annual Meeting of Shareholders on May 21, 2026, virtually.
- The meeting agenda includes proposals to elect directors, declassify the board, eliminate supermajority voting requirements, ratify independent auditors, approve executive compensation, and amend the 2020 Equity Incentive Plan.
- The company is seeking shareholder approval to increase the number of shares available under the 2020 Equity Incentive Plan by 750,000 shares to continue attracting and retaining talent.
- Shareholders of record as of March 23, 2026, are eligible to vote.
- The company's CEO, Linda Findley, highlighted a turnaround strategy called 'Sleep Number Shifts' focused on product simplification, marketing enhancement, and distribution expansion.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the significant financial downturn reported for 2025, despite the company's stated turnaround efforts and positive governance proposals.
Positives
- The company is actively seeking to improve its corporate governance by proposing to declassify the board and eliminate supermajority voting requirements, which are generally viewed favorably by investors.
- The CEO, Linda Findley, has initiated a turnaround strategy ('Sleep Number Shifts') aimed at repositioning the brand, expanding reach, and reigniting growth.
- The company has reduced operating costs by $136 million compared to 2024, excluding restructuring costs.
- The bank agreement has been amended and extended through the end of 2027.
- The company is committed to aligning executive compensation with performance and has engaged with shareholders on this topic.
- The company has a strong focus on talent management and human capital development.
Negatives
- The company experienced a significant net sales decline of 16% in 2025, resulting in net sales of $1.4 billion.
- The company reported a net operating loss of $46.6 million in 2025, a substantial decrease from the previous year.
- Adjusted EBITDA decreased by 34.6% to $78.3 million in 2025.
- Diluted loss per share was $5.77 in 2025, a significant drop from $0.90 in 2024.
- The company used $3.3 million in cash from operating activities and $14.4 million for capital expenditures in 2025.
- The company's 2023 Performance Stock Units (PSUs) resulted in no payout due to underperformance against net sales, NOP, and ROIC goals.
- The 2025 Annual Incentive Plan (AIP) resulted in no payout as the adjusted EBITDA of $78.3 million was below the threshold goal of $100 million.
Risks
- The company's turnaround strategy ('Sleep Number Shifts') faces execution risks.
- The company's financial performance in 2025 indicates significant challenges, including declining sales and net operating losses.
- The company's ability to attract and retain talent may be impacted if the equity incentive plan is not approved, potentially hindering the transformation efforts.
- The company's stock price has been depressed, impacting the value of equity awards and potentially employee morale.
- The company's reliance on equity compensation to retain talent could be strained if the share count under the 2020 Equity Incentive Plan is insufficient.
Future Outlook
The company is focused on a turnaround strategy called 'Sleep Number Shifts' to reposition its brand, expand its reach, and reignite growth through product simplification, marketing enhancements, and distribution expansion. The company aims to create a strong foundation for sustainable growth.
Management Comments
- "Sleep Number is in a turnaround. I joined the Company in April 2025 and from day one, we were focused on driving value for shareholders, customers and team members."
- "Our strategy forward is called Sleep Number Shifts. It is a focused, company-wide effort to reposition our brand, expand our reach to new customer groups, and reignite growth."
- "We are refocusing on the consumer and setting the Company up for sustainable growth."
- "We still have a lot of work ahead of us, and I am optimistic about Sleep Number. This is a powerful brand, with a highly differentiated product."
- "The Board and management are committed to continuing to enhance the Company's governance."
Industry Context
StockSavvy.ai notes that Sleep Number's focus on a turnaround strategy and governance improvements comes at a time when the broader retail and consumer goods sectors are navigating economic uncertainties and evolving consumer preferences. The company's efforts to simplify its product offering and enhance marketing effectiveness are critical for regaining market share and driving growth in a competitive landscape.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Hilary A. Schneider | 2026 Annual Meeting | Retirement due to new board service limitations. | |
| Interim Chief Financial Officer | Robert P. Ryder | 2025-07-18 | Appointment. | |
| Chief Financial Officer | Francis Lee | Amy K. OKeefe | 2025-12-08 | New hire. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Declassification of Board | Proposal to amend Articles and Bylaws to declassify the Board, moving to annual elections for all directors. | Contingent on shareholder approval at 2026 Annual Meeting, with effect starting 2027. | Enhances corporate governance by allowing shareholders to vote on all directors annually. |
| Elimination of Supermajority Voting | Proposal to amend Articles to eliminate supermajority voting requirements in Article XIV (related to Directors) and Article XV (related to certain transactions), replacing them with majority voting requirements. | Contingent on shareholder approval at 2026 Annual Meeting. | Simplifies governance and aligns with common corporate practices, potentially increasing shareholder influence. |
| Board Leadership Structure | The Board has separated the Chair and CEO roles, with Phil Eyler as independent Chair and Linda Findley as CEO. | Following the 2025 Annual Meeting. | Provides clear separation of oversight and operational leadership. |
Related Party Transactions
- There were no related-party transactions during the year ended January 3, 2026, and none are currently contemplated.
Stakeholder Impact
- Shareholders: The proposed governance changes aim to improve accountability and shareholder alignment. The financial performance in 2025 may impact shareholder value.
- Employees: The company's turnaround strategy and equity incentive plan are designed to retain and motivate employees. Cost reductions may impact some employee roles.
- Customers: The 'Sleep Number Shifts' strategy includes simplifying product offerings and enhancing marketing to better connect with consumers.
Next Steps
- Shareholders to vote on the proposed resolutions at the 2026 Annual Meeting on May 21, 2026.
- If Proposal 2 passes, directors elected to terms expiring after the 2027 Annual Meeting will shorten their terms and stand for re-election in 2027 for a one-year term.
- If Proposal 7 passes, the company will have an additional 750,000 shares available under the 2020 Equity Incentive Plan.
Key Dates
| Date | Description |
|---|---|
| 2024-10-30 | Letter to Shareholders filed announcing plans to declassify the Board at the 2025 Annual Meeting. |
| 2025-05-28 | Shareholders approved Amendment No. 2 to the 2020 Plan to increase authorized shares by 500,000. |
| 2025-05-29 | Form 8-K filed stating the Board's agreement to resubmit declassification proposals to shareholders at the 2026 Annual Meeting. |
| 2026-01-03 | End of fiscal year 2025. |
| 2026-03-11 | Compensation Committee adopted an amendment to the 2020 Plan to increase authorized shares by 750,000. |
| 2026-03-17 | As of this date, approximately 583,000 shares remained available under the 2020 Plan. |
| 2026-03-23 | Record Date for determining shareholders entitled to vote at the Annual Meeting. |
| 2026-04-08 | Proxy materials first sent or made available to shareholders. |
| 2026-05-19 | Deadline for revoking a proxy or changing a vote by mail or written notice. |
| 2026-05-20 | Deadline for revoking a proxy or changing a vote by Internet or telephone. |
| 2026-05-21 | Date of the 2026 Annual Meeting of Shareholders. |
Recommendation
holdWhile the proposed governance changes are positive, the significant financial deterioration in 2025, including substantial sales declines and net operating losses, presents considerable risk. The success of the 'Sleep Number Shifts' turnaround strategy is uncertain. Therefore, a 'hold' recommendation is appropriate pending evidence of sustained operational improvement and a return to profitability.
Keywords
Sleep Number, Proxy Statement, Annual Meeting, Corporate Governance, Declassify Board, Executive Compensation, Equity Incentive Plan, Shareholder Vote, Turnaround Strategy, Financial Performance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.